Cefepime hydrochloride equivaqlent to cefepime (Auro-cefepime)
Cefepime hydrochloride equivaqlent to cefepime
Aurogen South Africa (Pty) Ltd
Registration
- Applicant
- Aurogen South Africa (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Auro-cefepime injection 500 MG EACH VIAL CONTAINS CEFEPIME HYDROCHLORIDE EQUIVAQLENT TO CEFEPIME 500,0 mg | 500 mgInjection | 41068941/20.1.1/0689 | Registered | Not determined | None |
| Auro-cefepime injection 1000 MG EACH VIAL CONTAINS CEFEPIME HYDROCHLORIDE EQUIVAQLENT TO CEFEPIME 1000,0 mg | 1000 mgInjection | 41069041/20.1.1/0690 | Registered | Not determined | None |
| Auro-cefepime injection 2000 MG EACH VIAL CONTAINS CEFEPIME HYDROCHLORIDE EQUIVAQLENT TO CEFEPIME 2000,0 mg | 2000 mgInjection | 41069141/20.1.1/0691 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.